TANCoV-1.3.20

N/A

Report date: 2025/01/26 15:56:18

Base Information

Drug NameTANCoV-1.3.20

Drug Alias NameTANCoV-1.3.20 SARS_CoV-2 vaccine (The Government of Tanzania/National Institute for Medical Research Mbeya Medical Research Centre)TANCoV-1.3.20 vaccine(The Government of Tanzania/National Institute for Medical Research Mbeya Medical Research Centre)

ClassificationVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTanzania

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesThe Government of Tanzania

China Registration ClassN/A

Develop Information

Active CompaniesNIMR - Mbeya Medical Research Center The Government of Tanzania

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A